B
Bo Lu
Researcher at Ohio State University
Publications - 390
Citations - 24905
Bo Lu is an academic researcher from Ohio State University. The author has contributed to research in topics: Cancer & Lung cancer. The author has an hindex of 58, co-authored 353 publications receiving 21823 citations. Previous affiliations of Bo Lu include Wuhan University of Technology & Wuhan University.
Papers
More filters
Journal ArticleDOI
Characteristics of nonfatal occupational injuries among U.S. workers with and without disabilities.
Junxin Shi,Stephen Gardner,Krista K. Wheeler,Meghan C. Thompson,Bo Lu,Lorann Stallones,Huiyun Xiang +6 more
TL;DR: U.S. workers with disabilities had a higher rate of occupational injuries and these injuries tended to be more severe and were more likely to be caused by overexertion/ strenuous movement or falls.
Journal ArticleDOI
Tobacco and Alcohol on Television: A Content Analysis of Male Adolescents' Favorite Shows.
Brittney Keller-Hamilton,Jacqueline Muff,Traci Blue,Bo Lu,Michael D. Slater,Megan E. Roberts,Amy K. Ferketich +6 more
TL;DR: Limiting tobacco and alcohol incidents on television could reduce adolescents’ risk of substance use and prevent adolescent initiation with these substances.
Journal ArticleDOI
The impact of driving time on pediatric TBI follow-up visit attendance
Jennifer P. Lundine,Jennifer P. Lundine,Jin Peng,David Chen,Kimberly Lever,Krista K. Wheeler,Jonathan I. Groner,Jonathan I. Groner,Jiabin Shen,Bo Lu,Henry Xiang,Henry Xiang +11 more
TL;DR: In this paper, the authors examined the effect of driving time on follow-up visit attendance for children hospitalized with a traumatic brain injury (TBI) and found that families who lived further from the hospital would show poorer attendance.
Journal ArticleDOI
Inference for proportional hazard model with propensity score
TL;DR: In this paper, the authors incorporate the propensity score into the Cox model for causal inference with survival data, and derive the asymptotic property of the maximum partial likelihood estimator when the model is correctly specified.
Journal ArticleDOI
A phase I study of nab-paclitaxel (nab-P) with carboplatin (C) and thoracic radiation (RT) in patients with locally advanced NSCLC.
TL;DR: In this article, a third of patients with NSCLC present with localized, unresectable disease and concurrent chemoradiotherapy is well established with weekly paclitaxel and C with median survi...